Holen Sie sich die Stockscreener-App
2.475
0.20%
-0.005
Schlusskurs vom Vortag:
$2.48
Offen:
$2.43
24-Stunden-Volumen:
3.04M
Relative Volume:
0.33
Marktkapitalisierung:
$2.34B
Einnahmen:
$1.31M
Nettoeinkommen (Verlust:
$-597.65M
KGV:
-2.5515
EPS:
-0.97
Netto-Cashflow:
$-425.62M
1W Leistung:
-1.00%
1M Leistung:
-4.81%
6M Leistung:
-14.36%
1J Leistung:
-33.47%
1-Tages-Spanne:
$2.38
$2.48
1-Wochen-Bereich:
$2.36
$2.61
52-Wochen-Spanne:
$1.83
$7.48
Immunitybio Inc Stock (IBRX) Company Profile
Firmenname
Immunitybio Inc
Sektor
Branche
Telefon
(844) 696-5235
Adresse
3530 JOHN HOPKINS COURT, SAN DIEGO
Vergleichen Sie IBRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IBRX
Immunitybio Inc
|
2.475 | 2.23B | 1.31M | -597.65M | -425.62M | -0.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
410.97 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.43 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.75 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
794.98 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
322.71 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Immunitybio Inc Stock (IBRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-20 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-03-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-01-10 | Eingeleitet | BTIG Research | Buy |
| 2023-05-12 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-08-03 | Eingeleitet | Jefferies | Buy |
Immunitybio Inc Aktie (IBRX) Neueste Nachrichten
Can machine learning forecast ImmunityBio Inc. recovery2025 Risk Factors & Free Low Drawdown Momentum Trade Ideas - newser.com
How ImmunityBio Inc. stock reacts to job market dataJuly 2025 Rallies & Daily Price Action Insights - newser.com
Tick level data insight on ImmunityBio Inc. volatilityJuly 2025 Recap & Free Fast Gain Swing Trade Alerts - newser.com
ImmunityBio Inc. stock trend outlook and recovery pathExit Point & Intraday High Probability Setup Alerts - newser.com
Will ImmunityBio Inc. rebound enough to break evenBear Alert & Community Consensus Picks - newser.com
Is ImmunityBio Inc. stock a buy on dipsJuly 2025 WrapUp & Community Trade Idea Sharing Platform - newser.com
How to recover losses in ImmunityBio Inc. stockJuly 2025 Rallies & Long-Term Investment Growth Plans - newser.com
Will ImmunityBio Inc. stock benefit from infrastructure spendingPortfolio Return Report & Low Drawdown Trading Strategies - newser.com
Published on: 2025-10-11 12:10:43 - earlytimes.in
ImmunityBio, Inc. (IBRX) Reports Strong Q2 Growth, Eyes Lung Cancer and NMIBC Expansion - MSN
Why ImmunityBio Inc. (26CA) stock is a strong analyst pick2025 Top Decliners & Daily Profit Focused Stock Screening - newser.com
Will EnGene Join The Ranks Of Merck, Ferring, And ImmunityBio In Bladder Cancer Treatment? - RTTNews
Will ImmunityBio Inc. stock outperform tech sector in 2025Quarterly Performance Summary & Precise Swing Trade Alerts - newser.com
Real time social sentiment graph for ImmunityBio Inc.2025 Pullback Review & Accurate Intraday Trading Signals - newser.com
Evaluating ImmunityBio Inc. with trendline analysis2025 Major Catalysts & Growth Oriented Trading Recommendations - newser.com
Is ImmunityBio Inc. (26CA) stock prepared for digital transitionJuly 2025 Technicals & Smart Allocation Stock Tips - newser.com
ImmunityBio Inc. stock retracement – recovery analysis2025 Investor Takeaways & AI Enhanced Trading Signals - newser.com
ANKTIVA Reimbursement Gains and UK Approval Might Change The Case For Investing In ImmunityBio (IBRX) - Sahm
ImmunityBio, Inc. (NASDAQ:IBRX) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
What Went Wrong With ImmunityBio’s Executives Claims — and How Investors Could Still Win - TradingView
ImmunityBio: A Small Bet Is Warranted (NASDAQ:IBRX) - Seeking Alpha
NMIBC Market to Experience Notable Growth in Forecast Span - openPR.com
Short interest data insights for ImmunityBio Inc.Earnings Growth Report & Technical Pattern Recognition Alerts - newser.com
Does ImmunityBio Inc. show high probability of reboundJuly 2025 Pullbacks & Stepwise Trade Signal Implementation - newser.com
What MACD and RSI say about ImmunityBio Inc.July 2025 Retail & Weekly High Return Stock Opportunities - newser.com
ImmunityBio (IBRX): Revisiting Valuation After ANKTIVA’s Regulatory Wins and New Growth Initiatives - Sahm
How high can ImmunityBio Inc. stock go2025 Volume Leaders & AI Powered Trade Plan Recommendations - newser.com
Wall Street Bullish on ImmunityBio (IBRX) Since the Announcement of New Findings From QUILT-3.055 Study - MSN
ImmunityBio’s (IBRX) ANKTIVA Shows Survival Gains in Lung Cancer Patients - MSN
Finanzdaten der Immunitybio Inc-Aktie (IBRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.02%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):